Expensive drugs forcing cancer doctors to weigh price

With new cancer drugs priced as high as $10,000 a month and more, and insurers tightening payment rules, patients who thought they were well-covered increasingly find themselves having to make life-altering decisions about what they can afford. As a result, cancer doctors trained to weigh side effects and efficacy are being regularly pulled into delicate discussions on cost.